Filana Therapeutics, Inc. (FLNA)
0.8824
-0.02
(-1.74%)
USD |
NASDAQ |
Sep 01, 16:00
0.8763
-0.01
(-0.69%)
After-Hours: 19:30
Filana Therapeutics Cash from Operations (TTM) : -28.70M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.70M |
| March 31, 2026 | -29.79M |
| December 31, 2025 | -32.25M |
| September 30, 2025 | -83.77M |
| June 30, 2025 | -95.84M |
| March 31, 2025 | -109.14M |
| December 31, 2024 | -116.93M |
| September 30, 2024 | -77.98M |
| June 30, 2024 | -86.21M |
| March 31, 2024 | -87.90M |
| December 31, 2023 | -82.02M |
| September 30, 2023 | -81.03M |
| June 30, 2023 | -76.05M |
| March 31, 2023 | -67.24M |
| December 31, 2022 | -77.51M |
| September 30, 2022 | -64.18M |
| June 30, 2022 | -57.40M |
| March 31, 2022 | -51.42M |
| December 31, 2021 | -30.20M |
| September 30, 2021 | -23.38M |
| June 30, 2021 | -10.79M |
| March 31, 2021 | -6.494M |
| December 31, 2020 | -5.382M |
| September 30, 2020 | -4.796M |
| June 30, 2020 | -3.355M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.104M |
| December 31, 2019 | -2.514M |
| September 30, 2019 | -2.49M |
| June 30, 2019 | -3.196M |
| March 31, 2019 | -3.731M |
| December 31, 2018 | -4.77M |
| September 30, 2018 | -5.642M |
| June 30, 2018 | -6.357M |
| March 31, 2018 | -8.428M |
| December 31, 2017 | -8.237M |
| September 30, 2017 | -9.831M |
| June 30, 2017 | -10.47M |
| March 31, 2017 | -10.54M |
| December 31, 2016 | -12.23M |
| September 30, 2016 | -12.75M |
| June 30, 2016 | -12.37M |
| March 31, 2016 | -11.05M |
| December 31, 2015 | -9.053M |
| September 30, 2015 | -8.068M |
| June 30, 2015 | -7.33M |
| March 31, 2015 | -7.973M |
| December 31, 2014 | -9.549M |
| September 30, 2014 | -8.44M |
| June 30, 2014 | -8.587M |
| March 31, 2014 | -7.797M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| CorMedix, Inc. | 253.62M |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -0.2899M |
| Breakthrough Chemistry, Inc. | -0.0066M |
| BioStem Technologies, Inc. | -5.919M |